Medplus Health Services' Q2 FY 2025-26 Quarterly Results
- 10 Nov 2025
Result Summary
- Medplus Health Services Ltd reported a 8.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 6.9%.
- Its expenses for the quarter were up by 8.2% QoQ and 5.7% YoY.
- The net profit increased 31.1% QoQ and increased 43.4% YoY.
- The earnings per share (EPS) of Medplus Health Services Ltd stood at 4.62 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 1696.80 | 1557.65 | 1587.77 | 8.9% | 6.9% |
Total Expenses | 1627.86 | 1504.88 | 1539.99 | 8.2% | 5.7% |
Profit Before Tax | 68.94 | 52.77 | 47.78 | 30.6% | 44.3% |
Tax | 13.43 | 10.42 | 9.08 | 28.9% | 47.9% |
Profit After Tax | 55.50 | 42.34 | 38.70 | 31.1% | 43.4% |
Earnings Per Share | 4.62 | 3.53 | 3.23 | 30.9% | 43.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Medplus Health Services Ltd is a prominent player in the healthcare sector, primarily engaged in the retail and distribution of pharmaceuticals and healthcare products. The company operates a network of retail outlets, providing a wide range of medicines, wellness, and personal care products. As a significant contributor to the healthcare industry, Medplus has established a reputation for accessibility and convenience with its expansive reach across various locations. The company is known for its customer-centric approach, ensuring the availability of essential healthcare products.
Recent developments in the company, as of the latest data, are not explicitly mentioned, but Medplus has been focusing on expanding its retail footprint and enhancing its product offerings to cater to a broader customer base. The company operates in a competitive market environment, continually adapting to changes in consumer preferences and regulatory landscapes.
Revenue
In the second quarter of the fiscal year 2026, Medplus Health Services Ltd reported a total income of ₹1696.80 crores. This figure represents an 8.9% increase quarter-over-quarter (QoQ) from ₹1557.65 crores in the first quarter of FY26 and a 6.9% year-over-year (YoY) growth compared to ₹1587.77 crores in the second quarter of FY25. The upward trajectory in revenue highlights the company's ability to increase its sales and market share during this period. This growth in total income reflects potential factors such as increased demand for pharmaceutical products or an expansion in the company's operational capacity.
Profitability
For the second quarter of FY26, Medplus Health Services Ltd achieved a profit before tax of ₹68.94 crores, which marks a substantial increase of 30.6% QoQ from ₹52.77 crores in Q1FY26 and a 44.3% YoY growth from ₹47.78 crores in Q2FY25. After accounting for a tax expense of ₹13.43 crores, the company's profit after tax stood at ₹55.50 crores, displaying a 31.1% QoQ increase from ₹42.34 crores in the previous quarter and a 43.4% YoY rise from ₹38.70 crores in the same quarter last year. The earnings per share (EPS) for Q2FY26 were ₹4.62, reflecting a QoQ growth of 30.9% from ₹3.53 in Q1FY26 and a YoY increase of 43.0% compared to ₹3.23 in Q2FY25.
Operating Metrics
Medplus Health Services Ltd reported total expenses amounting to ₹1627.86 crores in Q2FY26, which represents an 8.2% increase from ₹1504.88 crores in Q1FY26 and a 5.7% rise from ₹1539.99 crores in Q2FY25. The observed increase in expenses is consistent with the growth in total income, indicating operational scaling. The company's ability to manage expenses while achieving higher revenue and profitability metrics is evident in the financial data. These operating metrics provide insight into Medplus's financial management strategies as it continues to expand its operations and market presence.